Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

Anderson, Kenneth C.; Barry, Susan; Bashey, Asad; Bennett, Elizabeth; Bressler, Linda; Callander, Natalie Scott; Devine, Steven M.; Gabriel, Don A.; Gentile, Teresa; Giralt, Sergio; Hari, Parameswaran; Hars, Vera; Hassoun, Hani; Hofmeister, Craig C.; Horowitz, Mary M.; Hurd, David D.; Isola, Luis; Jiang, Chen; Kelly, Michael; Landau, Heather; Levitan, Denise; Linker, Charles; Martin, Thomas; Maziarz, Richard T.; McCarthy, Philip L.; McClune, Brian; Moreb, Jan S.; Owzar, Kouros; Pasquini, Marcelo C.; Postiglione, John; Qazilbash, Muzaffar H.; Richardson, Paul G.; Rosenbaum, Cara; Schlossman, Robert; Seiler, Michele; Shea, Thomas C.; Stadtmauer, Edward A.; Van Besien, Koen; Vij, Ravi; Weisdorf, Daniel J.

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

Abstract

Data are lacking on whether lenalidomide maintenance therapy prolongs the time to disease progression after autologous hematopoietic stem-cell transplantation in patients with multiple myeloma

Similar works

Full text

Open in the Core reader

Download PDF

Available Versions

Carolina Digital Repository

cdr.lib.unc.edu:ks65hm71r

Last time updated on 24/11/2020

Crossref

info:doi/10.1056%2Fnejmoa11140...

Last time updated on 16/02/2019